Tributary Capital Management LLC Sells 286 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Tributary Capital Management LLC reduced its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 0.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 207,131 shares of the company’s stock after selling 286 shares during the quarter. Addus HomeCare accounts for 2.0% of Tributary Capital Management LLC’s portfolio, making the stock its 11th largest position. Tributary Capital Management LLC owned about 1.14% of Addus HomeCare worth $25,964,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Quarry LP acquired a new stake in shares of Addus HomeCare during the 3rd quarter worth about $28,000. Farther Finance Advisors LLC increased its holdings in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after buying an additional 366 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Addus HomeCare by 25.7% in the third quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock valued at $124,000 after acquiring an additional 191 shares during the last quarter. Assetmark Inc. boosted its holdings in shares of Addus HomeCare by 11.5% in the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock worth $156,000 after acquiring an additional 121 shares in the last quarter. Finally, Dakota Wealth Management bought a new stake in Addus HomeCare during the 3rd quarter worth approximately $217,000. 95.35% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have commented on ADUS. Macquarie reissued an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. JMP Securities initiated coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price for the company. Oppenheimer increased their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. One research analyst has rated the stock with a sell rating, nine have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $134.22.

Insider Activity at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 39,750 shares of company stock worth $4,930,750 in the last ninety days. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $130.62 on Friday. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.72. The stock has a market capitalization of $2.37 billion, a price-to-earnings ratio of 29.89, a PEG ratio of 1.73 and a beta of 1.00. The firm has a fifty day moving average of $126.10 and a two-hundred day moving average of $126.96.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.03 earnings per share. As a group, research analysts forecast that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.